These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24578247)

  • 1. Stability of [-2]Pro-PSA in whole blood and serum: analysis for optimal measurement conditions.
    Igawa T; Takehara K; Onita T; Ito K; Sakai H
    J Clin Lab Anal; 2014 Jul; 28(4):315-9. PubMed ID: 24578247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination.
    Dittadi R; Fabricio ASC; Rainato G; Peroni E; Di Tonno F; Vezzù B; Mazzariol C; Squarcina E; Tammone L; Gion M
    Clin Chem Lab Med; 2019 Mar; 57(4):521-531. PubMed ID: 30218601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen.
    Sokoll LJ; Bruzek DJ; Dua R; Dunn W; Mohr P; Wallerson G; Eisenberger M; Partin AW; Chan DW
    Urology; 2002 Oct; 60(4 Suppl 1):24-30. PubMed ID: 12384159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples.
    Piironen T; Pettersson K; Suonpää M; Stenman UH; Oesterling JE; Lövgren T; Lilja H
    Urology; 1996 Dec; 48(6A Suppl):81-7. PubMed ID: 8973706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions.
    Woodrum D; French C; Shamel LB
    Urology; 1996 Dec; 48(6A Suppl):33-9. PubMed ID: 8973697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability of free and bound prostate-specific antigen.
    Cartledge JJ; Thompson D; Verril H; Clarkson P; Eardley I
    BJU Int; 1999 Nov; 84(7):810-4. PubMed ID: 10532977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and accuracy of total and free PSA values in samples stored at room temperature.
    Forde JC; Blake O; Crowley VE; Lynch TH
    Ir J Med Sci; 2016 Nov; 185(4):989-991. PubMed ID: 26443748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions.
    Jung K; Lein M; Brux B; Sinha P; Schnorr D; Loening SA
    Clin Chem Lab Med; 2000 Dec; 38(12):1271-5. PubMed ID: 11205692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.
    Ulmert D; Becker C; Nilsson JA; Piironen T; Björk T; Hugosson J; Berglund G; Lilja H
    Clin Chem; 2006 Feb; 52(2):235-9. PubMed ID: 16384894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of serum total and free prostate specific antigen under varying storage intervals and temperatures.
    Arcangeli CG; Smith DS; Ratliff TL; Catalona WJ
    J Urol; 1997 Dec; 158(6):2182-7. PubMed ID: 9366340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of [-2] pro PSA and phi index for early detection of prostate cancer: a prospective of 452 patients].
    Houlgatte A; Vincendeau S; Desfemmes F; Ramirez J; Benoist N; Bensalah K; Durand X
    Prog Urol; 2012 May; 22(5):279-83. PubMed ID: 22515924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Health Index outperforms other PSA derivatives in predicting a positive biopsy in men with tPSA <10 ng/mL: Largest prospective cohort in Taiwan.
    Fan YH; Pan PH; Lin TP; Huang TH; Wei TC; Huang IS; Lin CC; Huang EYH; Chung HJ; Huang WJS
    J Chin Med Assoc; 2019 Oct; 82(10):772-777. PubMed ID: 31356566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.
    Chiu PK; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF
    Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer].
    Lamy PJ; Montels F; Tosi D; Leizour B; Bascoul-Mollevi C; Castan F; Roques S; Nielloud F; Rebillard X
    Ann Biol Clin (Paris); 2013; 71(5):537-44. PubMed ID: 24113439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.
    Jung K; Brux B; Lein M; Knäbich A; Sinha P; Rudolph B; Schnorr D; Loening SA
    Urology; 1999 Jun; 53(6):1160-7; discussion 1167-8. PubMed ID: 10367846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.
    Lazzeri M; Haese A; Abrate A; de la Taille A; Redorta JP; McNicholas T; Lughezzani G; Lista G; Larcher A; Bini V; Cestari A; Buffi N; Graefen M; Bosset O; Le Corvoisier P; Breda A; de la Torre P; Fowler L; Roux J; Guazzoni G
    BJU Int; 2013 Aug; 112(3):313-21. PubMed ID: 23826841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer.
    Björk T; Lilja H; Christensson A
    BJU Int; 1999 Dec; 84(9):1021-7. PubMed ID: 10571627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
    Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
    BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
    Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.